ST
XBI icon

Spot Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Spot Trading’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$11.9M Buy
137,400
+60,500
+79% +$4.85M 0.2% 73
2017
Q2 		$5.93M Sell
76,900
-90,700
-54% -$6.43M 0.12% 186
2017
Q1 		$11.6M Buy
167,600
+10,000
+6% +$672K 0.39% 26
2016
Q4 		$9.33M Buy
157,600
+89,200
+130% +$5.51M 0.22% 79
2016
Q3 		$4.53M Buy
68,400
+25,600
+60% +$1.58M 0.09% 285
2016
Q2 		$2.31M Buy
42,800
+26,500
+163% +$1.45M 0.04% 608
2016
Q1 		$842K Buy
+16,300
New +$847K 0.01% 1215
2015
Q4 		– Sell
-7,200
Closed -$448K – 4134
2015
Q3 		$448K Buy
7,200
+5,700
+380% +$449K ﹤0.01% 2127
2015
Q2 		$126K Buy
+1,500
New +$117K ﹤0.01% 2982

Other funds holding XBI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

Spot Trading's XBI Position: Q3 2017 in Review

Spot Trading sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2017, closing a stake of 23,954 shares — an estimated $1.92M sold.

Spot Trading first reported a position in XBI in Q2 2016 and held it in 3 quarters. The position peaked at $7.51M in Q2 2016. 349 funds tracked by Wall St. Rank hold XBI as of Q3 2017.

  • Spot Trading reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2017 after selling out during the quarter.
  • Spot Trading sold 23,954 State Street SPDR S&P Biotech ETF shares in Q3 2017, an estimated $1.92M.
  • Spot Trading first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and held it in 3 quarters.
  • Spot Trading's State Street SPDR S&P Biotech ETF position peaked at $7.51M in Q2 2016.
  • 349 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.